Sign in to view content

“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2016

Related

Visual Loss After Cosmetic Facial Filler Injection
Min Kim, MD, PhD, MBA, FASRS
Annual Meeting Talks
2016
The Evolution of Pre-Existing Epiretinal Membranes Following Cataract Extraction
Gayatri S. Reilly, MD
Annual Meeting Talks
2016
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
Szilárd Kiss, MD
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more